BE886577A - Noyaux peptidiques cycliques et leur preparation - Google Patents

Noyaux peptidiques cycliques et leur preparation Download PDF

Info

Publication number
BE886577A
BE886577A BE1/10067A BE1010067A BE886577A BE 886577 A BE886577 A BE 886577A BE 1/10067 A BE1/10067 A BE 1/10067A BE 1010067 A BE1010067 A BE 1010067A BE 886577 A BE886577 A BE 886577A
Authority
BE
Belgium
Prior art keywords
emi
core
microorganism
nrrl
factor
Prior art date
Application number
BE1/10067A
Other languages
English (en)
French (fr)
Inventor
J B Abbott
D S Fukuda
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE886577A publication Critical patent/BE886577A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
BE1/10067A 1979-12-13 1980-12-10 Noyaux peptidiques cycliques et leur preparation BE886577A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10301679A 1979-12-13 1979-12-13

Publications (1)

Publication Number Publication Date
BE886577A true BE886577A (fr) 1981-06-10

Family

ID=22292913

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10067A BE886577A (fr) 1979-12-13 1980-12-10 Noyaux peptidiques cycliques et leur preparation

Country Status (3)

Country Link
JP (1) JPS56120655A (https=)
BE (1) BE886577A (https=)
ZA (1) ZA807816B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567236A (en) * 1983-07-18 1986-01-28 The Upjohn Co. Novel polymer blends
DE102004060750A1 (de) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden

Also Published As

Publication number Publication date
ZA807816B (en) 1982-07-28
JPH0238600B2 (https=) 1990-08-31
JPS56120655A (en) 1981-09-22

Similar Documents

Publication Publication Date Title
US4293489A (en) Derivatives of A-30912A nucleus
JP3307410B2 (ja) 新規ポリペプチド化合物およびそれらの製造方法
US4287120A (en) Derivatives of S31794/F-1 nucleus
CH646701A5 (fr) Noyaux peptidiques cycliques et leur preparation.
PL179581B1 (pl) kompozycja farmaceutyczna oraz substancja farmakologicznie czynna PL PL PL PL PL PL PL PL
US4320052A (en) Derivatives of A-30912A nucleus
US4293485A (en) Derivatives of S31794/F-1 nucleus
EP0032009A1 (en) Derivatives of cyclic peptide nuclei
US4293491A (en) Derivatives of A-30912H nucleus
FR2458587A1 (fr) Procede de production d'antibiotiques et microorganisme de production
US4293488A (en) Derivatives of A-30912B nucleus
JP2892699B2 (ja) 新規な抗生物質メルサシジンおよびその製法
US4293483A (en) Derivatives of A-30912A nucleus
US5643869A (en) Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
EP0031662A1 (en) Derivatives of cyclic peptide nuclei
FR2458551A1 (fr) Nouveaux antibiotiques, leur preparation et leur utilisation
US4293487A (en) Derivatives of A-30912D nucleus
BE886577A (fr) Noyaux peptidiques cycliques et leur preparation
FR2484408A1 (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
CA2052097A1 (en) Antiviral agent
BE886578A (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
BE886575A (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
FR2476074A1 (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
BE886576A (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
FR2642762A1 (fr) Janthinomycine

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 20001210